• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CitiusTech Acquires SDLC Partners to Drive Health Plan Digital Transformation

Share:

June 29, 2021

What You Should Know:

– CitiusTech, a provider of healthcare technology services, solutions, and platforms, announced today the strategic acquisition of SDLC Partners (SDLC), a Pittsburgh, PA-based provider of technology solutions to leading payer organizations.

– As the need for value-based innovative technology solutions grows, combining SDLC’s expertise in payer-focused solutions with CitiusTech’s industry presence and rich portfolio of complementary digital offerings, CitiusTech will be uniquely positioned to drive digital transformation in the health plan industry.

Source: Hitconsultant

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Medical Knowledge Group Continues Growth With Acquisiton Of Magnolia Innovation To Provide Expanded Services To Biopharmaceutical IndustryMedical Knowledge Group Continues Growth With Acquisiton Of Magnolia Innovation To Provide Expanded Services To Biopharmaceutical Industry
  • Stryker acquires HyperBranch Medical Technology, Inc.Stryker acquires HyperBranch Medical Technology, Inc.
  • Merck Completes Tender Offer to Acquire Immune DesignMerck Completes Tender Offer to Acquire Immune Design
  • Cellex Becomes First Company to Land FDA Emergency Use Authorization for COVID-19 Serology TestingCellex Becomes First Company to Land FDA Emergency Use Authorization for COVID-19 Serology Testing
  • Aetion, HealthVerity Collaborate on Real-world Data for COVID-19 Treatments, Aptar Pharma, Sonmol Co-developing Digital Respiratory Offerings and More Digital Health DealsAetion, HealthVerity Collaborate on Real-world Data for COVID-19 Treatments, Aptar Pharma, Sonmol Co-developing Digital Respiratory Offerings and More Digital Health Deals
  • Plandai Biotechnology in Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration MarketPlandai Biotechnology in Non-Binding Letter of Intent to Acquire Rights to Puriblood’s Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market
  • HCF Invests $5 Million in Australia’s First Venture Capitalist Fund for Health, Wellness, Sport and Fitness Start-UpsHCF Invests $5 Million in Australia’s First Venture Capitalist Fund for Health, Wellness, Sport and Fitness Start-Ups
  • Regulators Force Medical Device Manufacturers to Protect Against CyberattacksRegulators Force Medical Device Manufacturers to Protect Against Cyberattacks

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications